ACM Research Files 8-K for Regulatory Compliance, Nasdaq Listing Confirmed
Ticker: ACMR · Form: 8-K · Filed: Jan 9, 2024 · CIK: 1680062
| Field | Detail |
|---|---|
| Company | Acm Research, Inc. (ACMR) |
| Form Type | 8-K |
| Filed Date | Jan 9, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | neutral |
Complexity: simple
Sentiment: neutral
Topics: regulatory-filing, corporate-governance, compliance
TL;DR
**ACMR filed a routine 8-K, confirming regulatory compliance and Nasdaq listing.**
AI Summary
ACM Research, Inc. filed an 8-K on January 9, 2024, indicating it is providing written communications pursuant to Rule 425 under the Securities Act. This filing is a standard procedural update, confirming the company's Class A Common Stock (ACMR) is registered on The Nasdaq Stock Market LLC. For investors, this filing primarily serves as a confirmation of regulatory compliance and does not contain new financial results or operational changes, meaning it has a neutral impact on stock valuation.
Why It Matters
This filing confirms ACM Research's adherence to SEC regulations and its continued listing on Nasdaq, providing transparency and stability for shareholders.
Risk Assessment
Risk Level: low — This 8-K is a procedural filing and does not disclose any new financial or operational risks.
Analyst Insight
A smart investor would note this as a routine compliance filing, confirming the company's regulatory standing, but it offers no new financial data to influence investment decisions.
Key Players & Entities
- ACM Research, Inc. (company) — the registrant filing the 8-K
- The Nasdaq Stock Market LLC (company) — the exchange where ACMR Class A Common Stock is registered
- January 9, 2024 (date) — date of earliest event reported and filing date
- ACMR (company) — trading symbol for Class A Common Stock
FAQ
What is the purpose of this 8-K filing by ACM Research, Inc.?
This 8-K filing by ACM Research, Inc. is a current report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934, specifically indicating written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425).
What is the trading symbol and exchange for ACM Research, Inc.'s Class A Common Stock?
The trading symbol for ACM Research, Inc.'s Class A Common Stock, par value $0.0001 per share, is ACMR, and it is registered on The Nasdaq Stock Market LLC.
When was the earliest event reported in this 8-K filing?
The date of the earliest event reported in this 8-K filing was January 9, 2024.
What is ACM Research, Inc.'s state of incorporation and business address?
ACM Research, Inc. is incorporated in Delaware, and its business address is 42307 Osgood Road, Suite I, Fremont, California, 94539.
Is ACM Research, Inc. considered an emerging growth company according to this filing?
No, the filing indicates with an unchecked box that ACM Research, Inc. is not an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934.
Filing Stats: 500 words · 2 min read · ~2 pages · Grade level 12 · Accepted 2024-01-09 09:00:21
Key Financial Figures
- $0.0001 — stered Class A Common Stock, par value $0.0001 per share ACMR The Nasdaq Stock Mar
Filing Documents
- ef20018393_8k.htm (8-K) — 28KB
- ef20018393_ex99-1.htm (EX-99.1) — 12KB
- image01.jpg (GRAPHIC) — 120KB
- 0001140361-24-001418.txt ( ) — 344KB
- acmr-20240109.xsd (EX-101.SCH) — 4KB
- acmr-20240109_lab.xml (EX-101.LAB) — 22KB
- acmr-20240109_pre.xml (EX-101.PRE) — 16KB
- ef20018393_8k_htm.xml (XML) — 4KB
02
Item 2.02. Results of Operations and Financial Condition. On January 9, 2024, we issued a press release entitled "ACM Research Updates 2023 Revenue Outlook and Provides Initial Outlook for 2024 Revenue." The full text of the press release is furnished as Exhibit 99.1 hereto and is incorporated herein by reference. The information contained in this Item 2.02, including the exhibit furnished hereto, is intended to be furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, or the Securities Exchange Act of 1934, except as expressly set forth by specific reference in such filing.
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibits. Exhibit Description 99.1 Press Release of ACM Research, Inc. dated January 9, 2024 104 Cover Page Interactive Data File (embedded within the XBRL document) 2 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized. ACM RESEARCH, INC. By: /s/ Mark McKechnie Mark McKechnie Chief Financial Officer and Treasurer Dated: January 9, 2024 3